Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that doctors should thoroughly check postmenopausal women with sudden increased male traits for rare conditions like androgen-producing endometrial cancer.

The conclusion is that adult males with muscle weakness and hormonal imbalances should be tested for Kennedy's disease.

Spironolactone is effective for idiopathic hirsutism but has limited effects on other PCOS symptoms.

Prostate-specific antigen may be a new marker for excess male hormones in women with polycystic ovary syndrome.

Having enough iron improves the effectiveness of a specific hair loss treatment in women.

SHBG binding properties are unchanged in male liver cirrhosis patients.

Oophorectomy lowers testosterone and estrogen levels in both premenopausal and postmenopausal women, with postmenopausal women still producing significant testosterone.

The conclusion is that androgen receptor gene polymorphism might be a marker for polycystic ovary syndrome, but more research is needed.

The study found no link between baldness patterns and androgen levels in men with benign prostate enlargement or prostate cancer.

Androgen deprivation therapy doesn't lower the risk of death from COVID-19 in prostate cancer patients.

High androgen levels in postmenopausal women may suggest an ovarian tumor, and removing it can improve heart and metabolic health.

A woman's masculine features were caused by a rare ovarian tumor that produced male hormones.

Androgens increase norepinephrine release, promoting smooth muscle growth in male sex organs, which may contribute to benign prostatic hypertrophy.

Hirsutism is more linked to high androgen levels than acne or hair loss, and a mix of hormonal tests is best for diagnosis; certain treatments can reduce symptoms.

Finger length ratios are not linked to the number of specific gene repeats affecting testosterone sensitivity.

Overweight women with PCOS are more likely to have excess male hormones.

Spironolactone improved hair density and quality in women with hair loss.

A new treatment called SAMiRNA-AR68 increases hair count in people with hair loss, showing similar results to existing treatments but without side effects.

Scientists made a sensor that can detect a specific type of RNA related to androgen receptors quickly and accurately.

Removing an adrenal tumor can significantly reduce high androgen levels in postmenopausal women.

A woman's masculine symptoms were caused by a rare tumor in her left ovary, which was found using a special blood test.

The treatment significantly reduced hair growth and male hormone levels in hirsute women.

The patient's high testosterone was reduced by a medication that suppresses gonadotropin.

Ocimum basilicum L. and red Oryza sativa L. may help with hair loss and prostate issues.

Men with liver cancer have higher levels of a specific testosterone byproduct in their liver and blood, despite overall lower male hormone levels.

Androgens play a complex role in skin conditions like acne and hair loss in women, and normal blood levels don't always show true androgen status.

Higher androgen levels do not cause baldness in men.

The conclusion is that accurately identifying the cause of high androgen levels in women with PCOS is crucial and requires specific tests.

Androgenetic alopecia is a long-term, immune-related disorder that starts during puberty due to androgen secretion, and it might be improved with iron tablets, platelet transfusion, and anti-inflammation therapy.

Older obese women with PCOS have higher cardiovascular and metabolic risks despite lower androgen levels.